国际妇产科学杂志 ›› 2024, Vol. 51 ›› Issue (5): 486-491.doi: 10.12280/gjfckx.20240505

• 普通妇科疾病及相关研究: 综述 • 上一篇    下一篇

高强度聚焦超声技术在妇产科疾病中的应用进展

李慧敏, 胡雅莉, 张森淮, 马晓梅, 许飞雪()   

  1. 730000 兰州大学第一临床医学院(李慧敏,胡雅莉,张森淮,马晓梅);兰州大学第一医院妇产科(许飞雪)
  • 收稿日期:2024-05-29 出版日期:2024-10-15 发布日期:2024-10-17
  • 通讯作者: 许飞雪,E-mail:xfxsxq@163.com
  • 作者简介:审校者

Progress in the Application of High Intensity Focused Ultrasound Technology in Obstetric and Gynecological Diseases

LI Hui-min, HU Ya-li, ZHANG Sen-huai, MA Xiao-mei, XU Fei-xue()   

  1. The First School of Clinical Medicine of Lanzhou University, Lanzhou 730000, China (LI Hui-min, HU Ya-li, ZHANG Sen-huai, MA Xiao-mei); Department of Obstetrics and Gynecology, The First Hospital of Lanzhou University, Lanzhou 730000, China (XU Fei-xue)
  • Received:2024-05-29 Published:2024-10-15 Online:2024-10-17
  • Contact: XU Fei-xue, E-mail: xfxsxq@163.com

摘要:

高强度聚焦超声(high intensity focused ultrasound,HIFU)技术是一种无创的热组织消融方法,可以通过磁共振引导高强度聚焦超声(magnetic resonance guided high intensity focused ultrasound,MRgHIFU)或超声引导高强度聚焦超声(ultrasound guided high intensity focused ultrasound,USgHIFU)实现在线图像引导和治疗控制,HIFU具有非侵入性、非电离和治疗后并发症少的优点。作为一种非手术治疗方法,在过去的10年里,HIFU技术越来越多地被应用于妇产科疾病的治疗中。HIFU通过精准聚焦超声波能量实现组织消融,对于子宫肌瘤、宫颈病变、子宫腺肌病、外阴非肿瘤性上皮疾病、剖宫产瘢痕妊娠、腹壁子宫内膜异位症、子宫动静脉瘘、双胎反向动脉灌注序列征等妇产科疾病具有良好的疗效,其优点体现在减少并发症、适合有手术禁忌证患者以及缩短恢复时间,并且对未育女性也具有重要意义。尽管HIFU在妇产科疾病治疗中展现出积极前景,但仍需进一步研究以评估其长期效果和安全性。未来,HIFU有望成为妇科疾病治疗的新选择,造福更多患者。

关键词: 体外冲击波疗法, 平滑肌瘤, 子宫腺肌病, 宫颈上皮内瘤样病变, 乳头状瘤病毒科, 子宫内膜异位症, 外阴非肿瘤性上皮疾病, 剖宫产瘢痕妊娠, 子宫动静脉瘘, 双胎反向动脉灌注序列征

Abstract:

High intensity focused ultrasound (HIFU) technology is a non-invasive thermal tissue ablation method that can achieve image-guided therapy and treatment control through magnetic resonance guided high intensity focused ultrasound (MRgHIFU) or ultrasound guided high intensity focused ultrasound (USgHIFU). HIFU offers the advantages of being non-invasive, non-ionizing, and associated with fewer post-treatment complications. As a non-surgical treatment modality, HIFU technology has been increasingly applied in the treatment of obstetric and gynecological diseases over the past decade. HIFU achieves tissue ablation through precise focusing of ultrasound energy and has demonstrated efficacy in treating conditions such as uterine fibroids, cervical lesions, adenomyosis, non-neoplastic epithelial disorders of the vulva, caesarean scar pregnancy, abdominal wall endometriosis, uterine arteriovenous fistula, twin reversed arterial perfusion sequence, among others. Its benefits include reduced complications, suitability for patients with surgical contraindications, and shorter recovery times, which is particularly significant for women who have not yet had children. Although HIFU shows a promising outlook in the treatment of obstetric and gynecological diseases, further research is needed to assess its long-term effectiveness and safety. In the future, HIFU is expected to become a new treatment option for gynecological diseases, benefiting more patients.

Key words: Extracorporeal shock wave therapy, Leiomyoma, Adenomyosis, Cervical intraepithelial neoplasia, Papillomaviridae, Endometriosis, Non-neoplastic epithelial disorders of the vulva, Caesarean scar pregnancy, Uterine arteriovenous fistula, Twin reversed arterial perfusion sequence